PHRRF
Price
$0.10
Change
-$0.01 (-9.09%)
Updated
Oct 16 closing price
Capitalization
8.75M
RLYB
Price
$0.54
Change
-$0.01 (-1.82%)
Updated
Oct 17, 04:58 PM (EDT)
Capitalization
23.15M
20 days until earnings call
Interact to see
Advertisement

PHRRF vs RLYB

Header iconPHRRF vs RLYB Comparison
Open Charts PHRRF vs RLYBBanner chart's image
PharmaTher Holdings
Price$0.10
Change-$0.01 (-9.09%)
Volume$1.25M
Capitalization8.75M
Rallybio
Price$0.54
Change-$0.01 (-1.82%)
Volume$100
Capitalization23.15M
PHRRF vs RLYB Comparison Chart in %
PHRRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHRRF vs. RLYB commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHRRF is a Hold and RLYB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (PHRRF: $0.10 vs. RLYB: $0.55)
Brand notoriety: PHRRF and RLYB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHRRF: 191% vs. RLYB: 60%
Market capitalization -- PHRRF: $8.75M vs. RLYB: $23.15M
PHRRF [@Biotechnology] is valued at $8.75M. RLYB’s [@Biotechnology] market capitalization is $23.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHRRF’s FA Score shows that 0 FA rating(s) are green whileRLYB’s FA Score has 1 green FA rating(s).

  • PHRRF’s FA Score: 0 green, 5 red.
  • RLYB’s FA Score: 1 green, 4 red.
According to our system of comparison, RLYB is a better buy in the long-term than PHRRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHRRF’s TA Score shows that 4 TA indicator(s) are bullish while RLYB’s TA Score has 5 bullish TA indicator(s).

  • PHRRF’s TA Score: 4 bullish, 4 bearish.
  • RLYB’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RLYB is a better buy in the short-term than PHRRF.

Price Growth

PHRRF (@Biotechnology) experienced а -9.57% price change this week, while RLYB (@Biotechnology) price change was +0.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.26%. For the same industry, the average monthly price growth was +15.62%, and the average quarterly price growth was +78.54%.

Reported Earning Dates

RLYB is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLYB($23.1M) has a higher market cap than PHRRF($8.75M). PHRRF YTD gains are higher at: -40.012 vs. RLYB (-42.302). RLYB has more cash in the bank: 45.7M vs. PHRRF (1.29M).
PHRRFRLYBPHRRF / RLYB
Capitalization8.75M23.1M38%
EBITDAN/A-43.29M-
Gain YTD-40.012-42.30295%
P/E RatioN/AN/A-
RevenueN/A761K-
Total Cash1.29M45.7M3%
Total DebtN/A58K-
TECHNICAL ANALYSIS
Technical Analysis
PHRRFRLYB
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 2 days ago
88%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PHRRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UTSI2.35N/A
N/A
UTStarcom Holdings Corp
AOSL30.99-0.25
-0.80%
Alpha and Omega Semiconductor Limited
XEL81.10-0.70
-0.86%
Xcel Energy
KINS14.59-0.18
-1.22%
Kingstone Companies
EOSE15.45-2.83
-15.48%
Eos Energy Enterprises

PHRRF and

Correlation & Price change

A.I.dvisor tells us that PHRRF and HOTH have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHRRF and HOTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHRRF
1D Price
Change %
PHRRF100%
-8.22%
HOTH - PHRRF
24%
Poorly correlated
-6.54%
RLYB - PHRRF
20%
Poorly correlated
+3.38%
INNMF - PHRRF
20%
Poorly correlated
N/A
ANTX - PHRRF
20%
Poorly correlated
-4.07%
KMSTF - PHRRF
13%
Poorly correlated
N/A
More

RLYB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLYB has been loosely correlated with PROK. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RLYB jumps, then PROK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLYB
1D Price
Change %
RLYB100%
+3.38%
PROK - RLYB
45%
Loosely correlated
-4.10%
PXXLF - RLYB
44%
Loosely correlated
N/A
ARTV - RLYB
37%
Loosely correlated
-7.97%
ATXS - RLYB
37%
Loosely correlated
+1.43%
SEOVF - RLYB
34%
Loosely correlated
+0.06%
More